Nephropathic Cystinosis (CTNS) |
approved
|
219800 |
|
Nephrotic syndrome Type 1 (NPHS1) |
approved
|
256300 |
|
|
Nephrotic syndrome Type 2 (NPHS2) |
approved
|
600995 |
|
|
Netherton Syndrome |
approved
|
256500 |
|
|
Neurodegeneration with Brain Iron Accumulation 1 (NBIA1) |
approved
|
234200 |
|
|
Neurodegeneration with Brain Iron Accumulation 2A (NBIA2A) |
approved
|
256600 |
|
|
Neurodegeneration with Brain Iron Accumulation 2B (NBIA2B) |
approved
|
610217 |
|
|
Neurodegeneration with Brain Iron Accumulation 3 (NBIA3) |
approved
|
606159 |
|
|
Neurodegeneration with Brain Iron Accumulation 4 (NBIA4) |
approved
|
614298 |
|
|
Neurodegeneration with Brain Iron Accumulation 5 (NBIA5) |
approved
|
300894 |
|
|
Neurodegeneration with Brain Iron Accumulation 6 (NBIA6) |
approved
|
615643 |
|
|
Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism (NEDCAFD) |
approved
|
619244 |
|
|
Neurodevelopmental Disorder with Hypotonia, Neonatal Respiratory Insufficiency, and Thermodysregulation (NEDHRIT) |
approved
|
618797 |
|
Neurodevelopmental disorder with impaired speech and hyperkinetic movements (NEDISHM) |
approved
|
618425 |
|
|
Neurodevelopmental Disorder with Progressive Microcephaly Spasticity and Brain Anomalies (NDMSBA) |
approved
|
617527 |
|
|
Neurofibromatosis type 1 (NF1) |
approved
|
162200 |
|
Neurofibromatosis Type 2 (NF2) |
approved
|
101000 |
|
Neurogenic muscle weakness, Ataxia, Retinitis Pigmentosa (NARP) |
approved
|
551500 |
|
Neuronal Ceroid Lipofuscinosis Type 3 (Batten disease) (CLN3) |
approved
|
204200 |
|
Neuronopathy Distal Hereditary Motor, Type 2C (HMN2C) |
approved
|
613376 |
|
|